LeMaitre Vascular Debt to Equity Ratio 2010-2023 | LMAT
Current and historical debt to equity ratio values for LeMaitre Vascular (LMAT) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. LeMaitre Vascular debt/equity for the three months ending December 31, 2023 was 0.00.
| LeMaitre Vascular Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-12-31 | $0.05B | $0.30B | 0.16 |
| 2023-09-30 | $0.05B | $0.29B | 0.16 |
| 2023-06-30 | $0.04B | $0.28B | 0.15 |
| 2023-03-31 | $0.04B | $0.27B | 0.15 |
| 2022-12-31 | $0.04B | $0.27B | 0.16 |
| 2022-09-30 | $0.04B | $0.26B | 0.16 |
| 2022-06-30 | $0.04B | $0.26B | 0.16 |
| 2022-03-31 | $0.04B | $0.26B | 0.13 |
| 2021-12-31 | $0.04B | $0.25B | 0.15 |
| 2021-09-30 | $0.04B | $0.25B | 0.16 |
| 2021-06-30 | $0.06B | $0.19B | 0.33 |
| 2021-03-31 | $0.07B | $0.18B | 0.39 |
| 2020-12-31 | $0.08B | $0.17B | 0.47 |
| 2020-09-30 | $0.10B | $0.16B | 0.63 |
| 2020-06-30 | $0.10B | $0.15B | 0.68 |
| 2020-03-31 | $0.04B | $0.15B | 0.24 |
| 2019-12-31 | $0.04B | $0.15B | 0.27 |
| 2019-09-30 | $0.03B | $0.14B | 0.20 |
| 2019-06-30 | $0.03B | $0.14B | 0.18 |
| 2019-03-31 | $0.03B | $0.13B | 0.20 |
| 2018-12-31 | $0.02B | $0.13B | 0.18 |
| 2018-09-30 | $0.02B | $0.13B | 0.15 |
| 2018-06-30 | $0.02B | $0.12B | 0.14 |
| 2018-03-31 | $0.02B | $0.11B | 0.14 |
| 2017-12-31 | $0.02B | $0.11B | 0.15 |
| 2017-09-30 | $0.02B | $0.11B | 0.14 |
| 2017-06-30 | $0.01B | $0.10B | 0.14 |
| 2017-03-31 | $0.02B | $0.09B | 0.16 |
| 2016-12-31 | $0.01B | $0.09B | 0.17 |
| 2016-09-30 | $0.02B | $0.09B | 0.17 |
| 2016-06-30 | $0.01B | $0.08B | 0.15 |
| 2016-03-31 | $0.01B | $0.08B | 0.16 |
| 2015-12-31 | $0.01B | $0.08B | 0.17 |
| 2015-09-30 | $0.01B | $0.07B | 0.17 |
| 2015-06-30 | $0.01B | $0.07B | 0.18 |
| 2015-03-31 | $0.01B | $0.07B | 0.17 |
| 2014-12-31 | $0.01B | $0.07B | 0.20 |
| 2014-09-30 | $0.02B | $0.07B | 0.24 |
| 2014-06-30 | $0.01B | $0.07B | 0.19 |
| 2014-03-31 | $0.01B | $0.06B | 0.22 |
| 2013-12-31 | $0.01B | $0.06B | 0.25 |
| 2013-09-30 | $0.01B | $0.06B | 0.20 |
| 2013-06-30 | $0.01B | $0.05B | 0.18 |
| 2013-03-31 | $0.01B | $0.05B | 0.19 |
| 2012-12-31 | $0.01B | $0.05B | 0.19 |
| 2012-09-30 | $0.01B | $0.05B | 0.18 |
| 2012-06-30 | $0.01B | $0.05B | 0.15 |
| 2012-03-31 | $0.01B | $0.05B | 0.14 |
| 2011-12-31 | $0.01B | $0.05B | 0.15 |
| 2011-09-30 | $0.01B | $0.05B | 0.20 |
| 2011-06-30 | $0.01B | $0.05B | 0.17 |
| 2011-03-31 | $0.01B | $0.05B | 0.17 |
| 2010-12-31 | $0.01B | $0.05B | 0.21 |
| 2010-09-30 | $0.01B | $0.05B | 0.20 |
| 2010-06-30 | $0.01B | $0.05B | 0.18 |
| 2010-03-31 | $0.01B | $0.05B | 0.17 |
| 2009-12-31 | $0.01B | $0.05B | 0.18 |
| 2009-09-30 | $0.01B | $0.05B | 0.19 |
| 2009-06-30 | $0.01B | $0.05B | 0.18 |
| 2009-03-31 | $0.01B | $0.04B | 0.16 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.437B | $0.193B |
| LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $188.944B | 24.52 |
| Stryker (SYK) | United States | $129.029B | 31.99 |
| Medtronic (MDT) | Ireland | $106.531B | 15.08 |
| Boston Scientific (BSX) | United States | $98.941B | 32.90 |
| EssilorLuxottica (ESLOY) | France | $97.450B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.229B | 0.00 |
| Haleon (HLN) | United Kingdom | $36.803B | 28.79 |
| ResMed (RMD) | United States | $27.225B | 27.22 |
| Zimmer Biomet Holdings (ZBH) | United States | $25.477B | 16.40 |
| Terumo (TRUMY) | Japan | $24.641B | 34.80 |
| Baxter (BAX) | United States | $20.333B | 14.83 |
| Koninklijke Philips (PHG) | Netherlands | $18.954B | 15.12 |
| Insulet (PODD) | United States | $12.180B | 63.95 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.404B | 0.00 |
| Demant (WILYY) | Denmark | $10.167B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.567B | 25.52 |
| BellRing Brands (BRBR) | United States | $7.140B | 38.39 |
| Haemonetics (HAE) | United States | $4.311B | 22.05 |
| Lantheus Holdings (LNTH) | United States | $4.130B | 10.66 |
| Perrigo (PRGO) | Ireland | $4.083B | 11.68 |
| GN Store Nord (GNNDY) | Denmark | $3.675B | 23.80 |
| Prestige Consumer Healthcare (PBH) | United States | $3.383B | 15.99 |
| Envista Holdings (NVST) | United States | $3.289B | 12.51 |
| QuidelOrtho (QDEL) | United States | $2.772B | 10.06 |
| Green Thumb Industries (GTBIF) | United States | $2.630B | 83.33 |
| Neogen (NEOG) | United States | $2.601B | 25.02 |
| ICU Medical (ICUI) | United States | $2.366B | 17.66 |
| TG Therapeutics (TGTX) | United States | $2.173B | 703.50 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.039B | 0.00 |
| Owens & Minor (OMI) | United States | $1.914B | 18.38 |
| Verano Holdings (VRNOF) | United States | $1.710B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.644B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.505B | 46.88 |
| InMode (INMD) | Israel | $1.486B | 7.69 |
| AdaptHealth (AHCO) | United States | $1.313B | 9.88 |
| Warby Parker (WRBY) | United States | $1.282B | 0.00 |
| AtriCure (ATRC) | United States | $1.108B | 0.00 |
| MacroGenics (MGNX) | United States | $1.060B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.710B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.706B | 15.26 |
| Cresco Labs (CRLBF) | United States | $0.691B | 0.00 |
| Evolus (EOLS) | United States | $0.689B | 0.00 |
| Quanterix (QTRX) | United States | $0.653B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.636B | 0.00 |
| Valneva SE (VALN) | France | $0.590B | 0.00 |
| Jin Medical (ZJYL) | China | $0.541B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.535B | 11.59 |
| TerrAscend (TSNDF) | Canada | $0.524B | 0.00 |
| PetIQ (PETQ) | United States | $0.476B | 17.78 |
| Biote (BTMD) | United States | $0.439B | 4.18 |
| ZimVie (ZIMV) | United States | $0.428B | 26.23 |
| OraSure Technologies (OSUR) | United States | $0.414B | 6.85 |
| Zynex (ZYXI) | United States | $0.385B | 44.30 |
| Surmodics (SRDX) | United States | $0.376B | 40.65 |
| Aurora Cannabis (ACB) | Canada | $0.343B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.315B | 31.31 |
| Cerus (CERS) | United States | $0.314B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.278B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.250B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.245B | 14.95 |
| Veru (VERU) | United States | $0.224B | 0.00 |
| Omeros (OMER) | United States | $0.196B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.194B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.185B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.182B | 0.00 |
| High Tide (HITI) | Canada | $0.178B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.161B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.135B | 68.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 21.52 |
| Jushi Holdings (JUSHF) | United States | $0.132B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.114B | 0.00 |
| InterCure (INCR) | Israel | $0.112B | 18.85 |
| Cellectar Biosciences (CLRB) | United States | $0.107B | 0.00 |
| Fonar (FONR) | United States | $0.106B | 9.15 |
| Safety Shot (SHOT) | United States | $0.098B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.098B | 0.00 |
| MariMed (MRMD) | United States | $0.098B | 0.00 |
| Brainsway (BWAY) | Israel | $0.088B | 0.00 |
| Chimerix (CMRX) | United States | $0.082B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.070B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.068B | 4.41 |
| United Health Products (UEEC) | United States | $0.052B | 0.00 |
| Apyx Medical (APYX) | United States | $0.048B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.045B | 0.00 |
| Bright Green (BGXX) | United States | $0.041B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.035B | 13.75 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.025B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.021B | 0.00 |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| Agape ATP (ATPC) | $0.018B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.011B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 71.73 |
| ProSomnus (OSA) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |